GALT · Galectin Therapeutics Inc · Documents
$3.19
-0.19 (-5.62%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$321.71M
Shares
100.85M
Volume · Oct 23
195.22K
Avg daily vol (3M)
303.16K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-05-15 | — | |
| 8-K | — | 2024-03-29 | — | |
| 10-K | — | 2024-03-29 | 2023-12-31 | |
| 8-K | — | 2023-12-11 | 2023-12-07 | |
| 8-K | — | 2023-12-07 | — | |
| 10-Q | — | 2023-11-13 | 2023-09-30 | |
| 8-K/A | — | 2023-11-13 | 2023-08-14 | |
| 8-K | — | 2023-11-13 | 2023-08-14 | |
| DEF 14A | — | 2023-10-06 | 2023-12-07 | |
| DEFA14A | — | 2023-10-06 | — | |
| 10-Q | — | 2023-08-14 | 2023-06-30 | |
| 8-K | — | 2023-08-14 | — | |
| 10-Q | — | 2023-05-15 | 2023-03-31 | |
| 8-K | — | 2023-05-15 | — | |
| S-3 | — | 2023-04-14 | — | |
| 8-K | — | 2023-03-30 | — | |
| 10-K | — | 2023-03-30 | 2022-12-31 | |
| 8-K | — | 2023-03-02 | — | |
| 8-K | — | 2023-01-05 | — | |
| 8-K | — | 2022-12-06 | 2022-12-01 | |
| 8-K | — | 2022-12-01 | — | |
| 10-Q | — | 2022-11-14 | 2022-09-30 | |
| 8-K | — | 2022-11-14 | — | |
| DEFA14A | — | 2022-10-17 | — | |
| DEF 14A | — | 2022-10-17 | 2022-12-01 | |
| 8-K | — | 2022-10-12 | — | |
| 8-K | — | 2022-10-06 | — | |
| PRE 14A | — | 2022-10-06 | 2022-12-01 | |
| 8-K | — | 2022-08-15 | — | |
| 10-Q | — | 2022-08-15 | 2022-06-30 | |
| 8-K | — | 2022-07-26 | 2022-07-25 | |
| 8-K | — | 2022-05-16 | — | |
| 10-Q | — | 2022-05-16 | 2022-03-31 | |
| 8-K | — | 2022-04-14 | — | |
| 8-K | — | 2022-03-31 | — | |
| 10-K | — | 2022-03-31 | 2021-12-31 | |
| 8-K | — | 2021-12-21 | 2021-12-20 | |
| 8-K | — | 2021-12-07 | 2021-12-03 | |
| 8-K | — | 2021-12-03 | — | |
| 8-K | — | 2021-11-15 | — | |
| 10-Q | — | 2021-11-15 | 2021-09-30 | |
| DEF 14A | — | 2021-10-12 | 2021-12-03 | |
| PRE 14A | — | 2021-09-22 | 2021-12-03 | |
| 8-K | — | 2021-09-21 | 2021-09-17 | |
| 8-K | — | 2021-09-13 | — | |
| 8-K | — | 2021-08-16 | — | |
| 10-Q | — | 2021-08-16 | 2021-06-30 | |
| 8-K | — | 2021-07-26 | — | |
| 8-K | — | 2021-07-09 | — | |
| 10-Q | — | 2021-05-17 | 2021-03-31 |
Showing 51–100 of 125 filings
Key facts
CIK
1133416
CUSIP
363225202
13F (30d)
15 filings
15 filers
Visit website
Investor relations